Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

doi:10.1200/JCO.23.01680

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).

Journal of clinical oncology : official journal of the American Society of Clinical Oncology - 20 Aug 2024

Nowak Jonathan A, Twombly Tyler, Ma Chao, Shi Qian, Haruki Koichiro, Fujiyoshi Kenji, Väyrynen Juha, Zhao Melissa, Knight James, Mane Shrikant, Shergill Ardaman, Kumar Pankaj, Couture Felix, Kuebler Philip, Krishnamurthi Smitha, Tan Benjamin, Philip Philip, O'Reilly Eileen M, Shields Anthony F, Ogino Shuji, Fuchs Charles S, Meyerhardt Jeffrey A

Abstract excerpt

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or secondary analyses are not yet available. Clinical Trial Updates provide an opportunity to disseminate additional results from studies, published in JCO or elsewhere, for which the primary end point has already been...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antineoplastic Combined Chemotherapy Protocols

Share to Chemotherapy, Adjuvant

Share to Class I Phosphatidylinositol 3-Kinases

Share to Colonic Neoplasms

Share to Cyclooxygenase 2 Inhibitors

Share to Disease-Free Survival

Share to Neoplasm Staging

Source

Open in PubMed Open full text

Identifiers

PMID: 38889377
DOI: 10.1200/JCO.23.01680
PMCID: PMC11392453

Genes

PIK3CA

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improved Survival With Adjuvant Cyclooxygenase 2 Inhibition in PIK3CA-Activated Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance).PMID 38889377Read ↗

Adjuvant aspirin for colorectal cancer with PIK3CA-mutated and COX-2 overexpressed tumours: the ASCOLT translational research study and meta-analysis.Semantic proximity Read ↗

Adjuvant aspirin and Cyclooxygenase-2 inhibitors in resected, PIK3CA-mutated colorectal cancer: A systematic review and meta-analysis of randomized controlled trials.Semantic proximity Read ↗

Examining the impact of regular aspirin use and PIK3CA mutations on survival in stage 2 colon cancer.Semantic proximity Read ↗

KRAS and BRAF Mutations in Stage II and III Colon Cancer: A Systematic Review and Meta-Analysis.Semantic proximity Read ↗

Evaluation of PIK3CA mutation as a predictor of benefit from nonsteroidal anti-inflammatory drug therapy in colorectal cancer.Semantic proximity Read ↗

Aspirin use, tumor PIK3CA mutation, and colorectal-cancer survival.Semantic proximity Read ↗

Evaluation of PTGS2 Expression, PIK3CA Mutation, Aspirin Use and Colon Cancer Survival in a Population-Based Cohort StudySemantic proximity Read ↗

Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population‐based studySemantic proximity Read ↗

Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.Semantic proximity Read ↗

Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation.Semantic proximity Read ↗

Optimizing Adjuvant Therapy for Localized Colon Cancer and Treatment Selection in Advanced Colorectal Cancer.Semantic proximity Read ↗

Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.